Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Dr. Dan Voytas, Co-Founder & Chief Science Officer of Calyxt, Elected to the National Academy of Sciences

CBUS

MINNEAPOLIS & ST. PAUL, Minn.

Calyxt, Inc. (NASDAQ: CLXT), a healthy food ingredient company, announced today that its co-founder and Chief Science Officer, Dan Voytas, Ph.D., has been elected to the National Academy of Sciences (NAS) for his many contributions to the field of plant genomics, one of which is being an inventor of the TALEN® gene-editing technology.

Dan Voytas graduated summa cum laude from Harvard College in 1984 and received his Ph.D. in genetics from Harvard Medical School in 1990. He completed his postdoctoral research at Johns Hopkins University School of Medicine, and in 1992, joined the faculty at Iowa State University. Shortly before the inception of Calyxt, Dan Voytas assumed his role as a professor in the Department of Genetics, Cell Biology and Development at the University of Minnesota (UMN), and now holds the position of Director of the UMN’s Center for Precision Plant Genomics. Among his other achievements, he is also an elected Fellow of the American Association for the Advancement of Science.

In 2009, Dr. Dan Voytas, in collaboration with Dr. Adam Bogdanove and members of their labs, developed an advanced plant breeding technology called TALEN®. Using TALEN®, it is possible to precisely target existing genes within a crop’s genome to more quickly, efficiently and cost-effectively develop traits of value for consumers, including those that help improve nutrition and sustainability.

About Calyxt

Calyxt is committed to making the food you love a healthier choice. The care we take extends beyond nutritional value. We partner with farmers and food companies to deliver traceable plant-based products developed to be healthier and more sustainable than their conventional counterparts. We use cutting edge plant breeding techniques to develop products that help improve diets by reducing bad fats, allergens and toxins. Today oil from our high oleic soybean plants has lower saturated fats than commodity soybean oil. We are also developing high fiber wheat designed to provide an excellent source of daily fiber when incorporated into wheat-based foods. We continuously pursue innovation to deliver good food that is good for you.

Calyxt is located in Roseville, MN, and is listed on the Nasdaq market (ticker: CLXT). For further information please visit our website at www.calyxt.com.

Calyxt™ and the corporate logo are trademarks owned by Calyxt, Inc.

Forward-Looking Statements

This communication may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including those factors discussed under the caption entitled “Risk Factors” in Calyxt’s Annual Report on Form 10-K for the year ended December 31, 2018 along with other Calyxt subsequent filings with the U.S. Securities and Exchange Commission. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by applicable laws.

Media
Jennifer Moore, VP Communications
Phone: +1 (917) 580-1088
email: media@calyxt.com

Breanna Welke
Bellmont Partners
Phone: +1 (612) 255-1122
email: breanna@bellmontpartners.com

Investor Relations
Simon Harnest, VP Corporate Strategy and Finance
Phone: +1 (646) 385-9008
email: simon.harnest@calyxt.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today